EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1
EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1
In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances
EU. Hazardous Substances for Purposes of Art. 5(2) and Annex I of Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices, 5 May 2017, as corrected 27 December 2019
This list contains a non-exhaustive inventory of hazardous substances for purposes of Regulation (EU) 2017/746, including Chap. 2 (Placing on the market and putting into service) and Annex I (General Safety and Performance Requirements). It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).
Last updated 17 mai 2024. Database contains 4917 unique substances/entries.
Filter the list
|
-
|
115850-69-6
|
Repr. 1B; Acute Tox. 4; STOT RE 2 |
Details | |||
|
-
|
115937-89-8
|
Repr. 1B; Acute Tox. 4; STOT RE 2 |
Details | |||
|
-
|
95342-41-9
|
END Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
|
-
|
852541-21-0
|
END Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
|
-
|
741687-98-9
|
END Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
|
-
|
135821-03-3
|
VPVB very Persistent and very Bioaccumulative (article 57e) |
Details | |||
|
-
|
135821-74-8
|
VPVB very Persistent and very Bioaccumulative (article 57e) |
Details | |||
|
-
|
852541-30-1
|
END Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
|
-
|
852541-25-4
|
END Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
|
-
|
166900-80-7
|
Repr. 2; Acute Tox. 4; STOT RE 2; Skin Sens. 1 |
Details | |||